Received Apr 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
severe localized cellulitis reaction, at injection site; Information has been received from other company on 09-Apr-2025. This spontaneous report was received from a pharmacy student calling on behalf of facility referring to a female patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date (reported as 5 to 10 years ago), the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) (also reported as Pfizer product, conflicting information), administered in the deltoid (unknown if left or right) for prophylaxis (strength, route of administration, dose, lot # and expiration date were not reported). On an unknown date after the vaccination (5 to 10 years ago), the patient had severe localized cellulitis reaction to the vaccine, at injection site in the deltoid, unknown if left or right (Vaccination site cellulitis). The treatment for the event was reported as unknown. The reporter was wondering if that was any information on that because they were looking to give Pneumococcal vaccine conj 20v (CRM197) (PREVNAR 20) to her now. At the reporting time, the outcome of vaccination site cellulitis was unknown. The action taken with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) was reported as not applicable. The reporter considered the event of vaccination site cellulitis to be related to Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23). Additional information is not expected.
Comments: not reported